Society of Gynecologic Oncology 2021 Annual Meeting News

0
384
SGO Annual Meeting 2021

The Society of Gynecologic Oncology (SGO) annual meeting, held virtually again this year, had investigators report some very interesting new research developments.  A partial list of pivotal data being presented is included below, but listen in to the highlights from the ASCO Post embedded below. 

Another important finding is summarized in the following video:

Pivotal Data on KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus Chemotherapy in Patients with Advanced Endometrial Cancer to be Presented During Plenary SessionAdditional Plenary Session to Include Investigational Data on Farletuzumab Combination with Carboplatin in Patients with Low CA125 Platinum-Sensitive Ovarian Cancer

Previous articleEndometriosis Bloating – News & Tips
Next articleOvarian cancer treatment with PARP inhibitors after recurrence
“I help and guide women to defeat gynecologic cancers and advanced pelvic conditions such as endometriosis, using a unique combination of minimally invasive robotic surgery, precision medicine therapies and complementary holistic natural support towards thriving in survivorship." Dr. Vasilev is the only physician quadruple board certified in Ob-Gyn, Gynecologic Oncology and Integrative & Holistic Medicine in the United States. He is an accomplished advanced robotic surgeon and serves as Medical Director of Integrative Medicine and Integrative Gynecologic Oncology at Providence Saint John's Health Center, Professor at John Wayne Cancer Institute in Santa Monica, California and is Clinical Professor at Loma Linda University School of Medicine. He is former faculty and professor at UC Irvine, UCLA, USC and City of Hope. He is an active member of multiple medical societies and has been nationally listed in "Best Doctors" for 18 years.